Variant report
Variant | esv1828988 |
---|---|
Chromosome Location | chr6:80159887-80161314 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540478749 | chr6:80159976-80159977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546600853 | chr6:80160016-80160017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532444266 | chr6:80160068-80160069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554314726 | chr6:80160151-80160152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72897772 | chr6:80160240-80160241 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs113862659 | chr6:80160241-80160242 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531244539 | chr6:80160249-80160250 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547774435 | chr6:80160284-80160285 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567862523 | chr6:80160325-80160326 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192095210 | chr6:80160339-80160340 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs61189442 | chr6:80160370-80160371 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs2803191 | chr6:80160375-80160376 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs540150779 | chr6:80160393-80160394 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556604805 | chr6:80160416-80160417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374421560 | chr6:80160430-80160431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535518429 | chr6:80160431-80160432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2803192 | chr6:80160434-80160435 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs572575720 | chr6:80160440-80160441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72897776 | chr6:80160459-80160460 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs554024040 | chr6:80160460-80160461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371573402 | chr6:80160487-80160488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552134531 | chr6:80160523-80160524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576993427 | chr6:80160549-80160550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545964937 | chr6:80160563-80160564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140926770 | chr6:80160611-80160612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185398966 | chr6:80160634-80160635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531632416 | chr6:80160643-80160644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565757653 | chr6:80160656-80160657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375050511 | chr6:80160679-80160680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368917729 | chr6:80160686-80160687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541430896 | chr6:80160731-80160732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9443671 | chr6:80160741-80160742 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs527401669 | chr6:80160744-80160745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146942858 | chr6:80160748-80160749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189461283 | chr6:80160807-80160808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192946453 | chr6:80160818-80160819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115725302 | chr6:80160860-80160861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570298191 | chr6:80160866-80160867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536108913 | chr6:80160872-80160873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555807877 | chr6:80160908-80160909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs59305033 | chr6:80160933-80160934 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs535144203 | chr6:80160942-80160943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558319495 | chr6:80160952-80160953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs578043107 | chr6:80160953-80160954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539043410 | chr6:80160965-80160966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545727185 | chr6:80160980-80160981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7740574 | chr6:80160990-80160991 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs184118177 | chr6:80160997-80160998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189440230 | chr6:80161007-80161008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111807866 | chr6:80161016-80161017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:80151000-80160800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr6:80153000-80163200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr6:80154200-80162400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr6:80158600-80162600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr6:80160200-80160400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr6:80160200-80163000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
7 | chr6:80160400-80161000 | Enhancers | HepG2 | liver |
8 | chr6:80160400-80162600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr6:80160800-80161000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr6:80160800-80161000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:80161000-80161200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |